Retatrutide is a synthetic peptide designed for research applications involving triple agonist activity at GIP, GLP-1, and glucagon receptors. This novel peptide is studied for its comprehensive metabolic signaling modulation in controlled laboratory settings. This high-purity peptide is manufactured under strict quality control standards to ensure consistency and reliability for advanced research use only. Not for human or veterinary use.
